Independent Director · ARS Pharmaceuticals, Inc. (SPRY)

Pratik Shah — ARS Pharmaceuticals Director Compensation (2025)

Fiscal year 2025 director compensation for Pratik Shah at ARS Pharmaceuticals, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 29, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

ARS Pharmaceuticals Director Compensation Table · the one fiscal year held
In US dollars, as ARS Pharmaceuticals reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$81,250——$240,000$9

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ARS Pharmaceuticals, Inc. DEF 14A filed April 29, 2026, accession 0001193125-26-191433, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2025

ARS Pharmaceuticals pays directors a $50,000 cash retainer.

The rest of the ARS Pharmaceuticals board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Brenton L. SaundersIndependent Director$435,459
Laura ShawverIndependent Director$417,751
Michael KellyIndependent Director$435,459
Peter A ThompsonIndependent Director$422,959
Peter KolchinskyIndependent Director$430,459
Phillip SchneiderIndependent Director$440,459
Rajeev DadooIndependent Director$425,459

The full ARS Pharmaceuticals compensation record

free company brief

This page is one director within ARS Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy